Bio
Angela Zhou serves as the Executive Editor of CAS Insights and the Lead Scientist in Life Sciences at CAS. Dr. Zhou earned her Ph.D. in Molecular Pharmacology and Toxicology from the University of Southern California, followed by postdoctoral training in cell biology at Johns Hopkins School of Medicine and specialized research in cancer therapeutics at Harvard Medical School.
Prior to joining CAS, Dr. Zhou held faculty positions at Missouri State University and Denison University, concentrating on teaching and research of cancer biology, cell signaling and biochemistry. At CAS, she leads a multidisciplinary team of research and data scientists who leverage comprehensive scientific databases. Dr. Zhou's unique blend of scientific expertise and data analytics leadership enables her team to deliver strategic intelligence, helping organizations navigate emerging trends and opportunities across chemistry, life sciences, and materials science.

極限環境微生物:過酷な環境の生物がもたらす生物医学と産業のイノベーション

絶滅分子復活が新たな抗生物質の可能性を開く

脂質ベースの薬物送達の未来

敵ではなく味方 - 健康のために腸内マイクロバイオームを利用する

ACE2という、疾病病因特定において潜在的に重要なレセプターを標的にする

